HCA Healthcare stock

HCA · NYSE · USD

Compare HCA Healthcare
$501.19Change from previous close: −2.07%Absolute change: −$10.59

Close · November 17, 2026

Price history

+5.36% over the period

1 year: from $477.10 (November 17, 2025) to $502.67 (November 17, 2026), +5.36%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$502.67
October 30, 2026$473.19
September 30, 2026$426.74
August 31, 2026$414.45
July 31, 2026$402.59
June 30, 2026$389.89
May 29, 2026$378.54
April 30, 2026$434.45
March 31, 2026$473.24
February 27, 2026$529.70
January 30, 2026$488.27
December 31, 2025$466.86
November 28, 2025$508.29
November 17, 2025$477.10

At a glance

TickerLandia's take on HCA Healthcare

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$353.99
52-wk high$556.52

−9.94% from the 52-week high

Analysts · 26 analysts

Average target$483.41−3.55% vs. price

Buy 15 · Hold 9 · Sell 2 · Buy

TickerLandia Fingerprint: HCA Healthcare

Compared with similar companies: high earnings stability, strong momentum, and high profitability.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

HCA Healthcare is pricier than in the past and in line with similar companies

On the latest fiscal year's earnings (2025), HCA Healthcare's P/E today is 17.7, above the median of its last 10 fiscal years (14.0; between 10.1 and 16.5 from 2016 to 2025). HCA Healthcare's P/E (trailing 12 months): 17.0, in line with the median of a group of 11 similar companies (17.2).

P/E compared with its history

Compared with 11 similar companies

HCA Healthcare's metrics compared with similar companies
MetricHCA HealthcarePosition in the groupBand
P/E (trailing 12 months)17.0Middle
Forward P/E16.3Middle
Operating margin15.3%Middle
EV/EBITDA10.2Middle
Net margin8.6%Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: HCA Healthcare. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$19.85B

Latest quarter · Q3 2026

Net income

$1.58B

Latest quarter · Q3 2026

Quarterly net margin

8.0%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$106.91B
P/E
17.0
EPS
$30.15
Volume
1.05M
Daily trading
€622.61M
Dividend yield
0.61%

How HCA Healthcare is changing

All results
  • Revenue grew 8.0% a year on average over the last 5 years

  • Profits turn into cash: free cash flow equal to 101% of net income

  • Shares outstanding down 30.3% in 5 years

Returns

HCA Healthcare returns with dividends

$1,000 invested in HCA Healthcare 5 years ago, on November 17, 2021, would be worth $2,149 today with dividends reinvested: +114.87% in total, +16.53% per year. On price alone it would be $2,061 (+106.13%).

PeriodHCA HealthcareS&P 500$1,000 becomes
1 month+10.51%−3.17%$1,105
6 months+18.48%+0.11%$1,185
Year to date+7.67%+8.34%$1,077
1 year+6.08%+11.15%$1,061
3 years+108.71%+64.30%$2,087
5 years+114.87%+58.18%$2,149
10 years+628.04%+239.10%$7,280

Over the last 6 months it has done better than 54% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

HCA Healthcare: technical analysis

HCA Healthcare is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 8.1% below its all-time closing high ($545.13, March 9, 2026).

Trend
Upward
RSI (14 sessions)
60
Between 30 and 70
vs 200-session average
+12.51%

Active signals

  • Golden cross: the 50-session average has crossed above the 200-session average.

    since November 9, 2026

Support and resistance

Price areas where HCA Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$552.28+10.19%3 touches, last on March 12, 2026
  2. Resistance$522.71+4.29%5 touches, last on November 5, 2026
  3. Last price$501.19
  4. Support$487.90−2.65%3 touches, last on October 27, 2026
  5. Support$478.88−4.45%2 touches, last on October 15, 2026
  6. Support$461.11−8.00%4 touches, last on April 2, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
0.23
Volatility (60 sessions, annualised)
33.0%
Largest fall in the last year
−33.72%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

HCA Healthcare: seasonality

Average monthly price change over 16 years

+6.4%Jan+1.1%Feb+0.9%Mar+0.2%Apr+0.7%May+1.1%Jun+5.1%Jul+0.3%Aug+0.3%Sep+1.5%Oct+4.2%Nov+0.6%Dec

Over the last 16 years, the strongest month for HCA Healthcare has been January: +6.38% on average, positive in 11 years out of 15. The weakest has been April: +0.23% on average, positive in 5 years out of 16. November, the current month, has been positive in 9 years out of 15 (+4.23% on average).

Show chart data
MonthAverageMedianPositive years
January+6.38%+6.30%11 of 15
February+1.14%+1.05%8 of 15
March+0.94%+2.54%10 of 15
April+0.23%−1.46%5 of 16
May+0.72%−2.01%7 of 16
June+1.09%−0.04%8 of 16
July+5.13%+2.89%10 of 16
August+0.29%+1.79%9 of 16
September+0.32%+0.83%11 of 16
October+1.45%+0.30%8 of 16
November+4.23%+3.97%9 of 15
December+0.57%+2.78%8 of 15

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

HCA Healthcare and its competitors

Hospitals, emergency rooms, urgent care and walk-in clinics are the facilities most patients associate with HCA Healthcare, Inc. Through its subsidiaries, the company runs a network across the United States that also includes ambulatory surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, and rehabilitation and physical therapy centers. Its general and acute care hospitals provide inpatient and intensive care, cardiac care, surgery, laboratory and radiology services, and emergency care, while physician practices, home health agencies and hospices extend care beyond the hospital walls.

Headquarters
Nashville, United States
Employees
230,000
Founded
1968
Chief executive
Samuel Hazen
HCA Healthcare and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
HCA HealthcareHCA$106.91B15.3%17.0+18.48%
Tenet HealthcareTHC$23.2B19.1%8.53+43.43%
Encompass HealthEHC$13.63B18.4%22.2+29.29%
Universal Health ServicesUHS$11.4B10.9%8.28+13.84%
DavitaDVA$10.96B15.2%13.2−13.39%
Ensign GroupENSG$10.59B8.6%28.9+4.70%

Same industry or related industries, similar size. Compare HCA Healthcare with its competitors · Full profile